166 related articles for article (PubMed ID: 34166830)
1. Unfractionated Heparin TID Dosing Regimen Is Associated With a Lower Rate of Pulmonary Embolism When Compared With BID Dosing in Patients Undergoing Craniotomy.
Thirunavu V; Kandula V; Shah P; Yerneni K; Karras CL; Abecassis ZA; Bloch O; Potts M; Jahromi B; Tate MC
World Neurosurg; 2021 Sep; 153():e147-e152. PubMed ID: 34166830
[TBL] [Abstract][Full Text] [Related]
2. Venous thromboembolic events in patients undergoing craniotomy for tumor resection: incidence, predictors, and review of literature.
Rinaldo L; Brown DA; Bhargav AG; Rusheen AE; Naylor RM; Gilder HE; Monie DD; Youssef SJ; Parney IF
J Neurosurg; 2019 Jan; 132(1):10-21. PubMed ID: 30611138
[TBL] [Abstract][Full Text] [Related]
3. Low-molecular-weight Heparin (enoxaparin) versus unfractionated heparin for venous thromboembolism prophylaxis in patients undergoing craniotomy.
Kandula V; Shah PV; Thirunavu VM; Yerneni K; Karras C; Abecassis ZA; Hopkins B; Bloch O; Potts MB; Jahromi BS; Tate MC
Clin Neurol Neurosurg; 2022 Dec; 223():107482. PubMed ID: 36283281
[TBL] [Abstract][Full Text] [Related]
4. Twice vs three times daily heparin dosing for thromboembolism prophylaxis in the general medical population: A metaanalysis.
King CS; Holley AB; Jackson JL; Shorr AF; Moores LK
Chest; 2007 Feb; 131(2):507-16. PubMed ID: 17296655
[TBL] [Abstract][Full Text] [Related]
5. Three-times-daily subcutaneous unfractionated heparin and neuraxial anesthesia: a retrospective review of 928 cases.
Davis JJ; Bankhead BR; Eckman EJ; Wallace A; Strunk J
Reg Anesth Pain Med; 2012; 37(6):623-6. PubMed ID: 22996202
[TBL] [Abstract][Full Text] [Related]
6. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism prophylaxis with unfractionated heparin in the hospitalized medical patient: the case for thrice daily over twice daily dosing.
Mahan CE; Pini M; Spyropoulos AC
Intern Emerg Med; 2010 Aug; 5(4):299-306. PubMed ID: 20177819
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and Safety of Twice- Versus Thrice-Daily Subcutaneous Heparin for Venous Thromboembolism Prophylaxis at a Large Academic Medical Center.
Wiethorn EE; Harrison S; Weeda ER; Bell CM
Ann Pharmacother; 2022 May; 56(5):541-547. PubMed ID: 34459268
[TBL] [Abstract][Full Text] [Related]
9. Epidurals in patients receiving thromboprophylaxis with unfractionated heparin three times a day: the value of activated partial thromboplastin time testing.
Pace M; Koury K; Gulur P
Anesth Analg; 2014 Nov; 119(5):1215-8. PubMed ID: 25225890
[TBL] [Abstract][Full Text] [Related]
10. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
11. Safety of perioperative subcutaneous heparin for prophylaxis of venous thromboembolism in patients undergoing craniotomy.
Macdonald RL; Amidei C; Lin G; Munshi I; Baron J; Weir BK; Brown F; Erickson RK; Hekmatpanah J
Neurosurgery; 1999 Aug; 45(2):245-51; discussion 251-2. PubMed ID: 10449068
[TBL] [Abstract][Full Text] [Related]
12. The incidence of postoperative thromboembolic complications following surgical resection of intracranial meningioma. A retrospective study of a large single center patient cohort.
Hoefnagel D; Kwee LE; van Putten EH; Kros JM; Dirven CM; Dammers R
Clin Neurol Neurosurg; 2014 Aug; 123():150-4. PubMed ID: 24956544
[TBL] [Abstract][Full Text] [Related]
13. Dosing frequency of unfractionated heparin thromboprophylaxis: a meta-analysis.
Phung OJ; Kahn SR; Cook DJ; Murad MH
Chest; 2011 Aug; 140(2):374-381. PubMed ID: 21349929
[TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolism: deep venous thrombosis and pulmonary embolism in a neurosurgical population.
Khaldi A; Helo N; Schneck MJ; Origitano TC
J Neurosurg; 2011 Jan; 114(1):40-6. PubMed ID: 20815694
[TBL] [Abstract][Full Text] [Related]
15. Timing of Pharmacologic Venous Thromboembolism Prophylaxis in Severe Traumatic Brain Injury: A Propensity-Matched Cohort Study.
Byrne JP; Mason SA; Gomez D; Hoeft C; Subacius H; Xiong W; Neal M; Pirouzmand F; Nathens AB
J Am Coll Surg; 2016 Oct; 223(4):621-631.e5. PubMed ID: 27453296
[TBL] [Abstract][Full Text] [Related]
16. Venous thromboembolism and intracranial hemorrhage after craniotomy for primary malignant brain tumors: a National Surgical Quality Improvement Program analysis.
Senders JT; Goldhaber NH; Cote DJ; Muskens IS; Dawood HY; De Vos FYFL; Gormley WB; Smith TR; Broekman MLD
J Neurooncol; 2018 Jan; 136(1):135-145. PubMed ID: 29039075
[TBL] [Abstract][Full Text] [Related]
17. Systematic Review of Safety and Cost-Effectiveness of Venous Thromboembolism Prophylaxis Strategies in Patients Undergoing Craniotomy for Brain Tumor.
Algattas H; Damania D; DeAndrea-Lazarus I; Kimmell KT; Marko NF; Walter KA; Vates GE; Jahromi BS
Neurosurgery; 2018 Feb; 82(2):142-154. PubMed ID: 28402497
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
Robertson L; Strachan J
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640
[TBL] [Abstract][Full Text] [Related]
19. Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery.
De A; Roy P; Garg VK; Pandey NK
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):57-61. PubMed ID: 19844176
[TBL] [Abstract][Full Text] [Related]
20. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer.
Akl EA; Kahale L; Sperati F; Neumann I; Labedi N; Terrenato I; Barba M; Sempos EV; Muti P; Cook D; Schünemann H
Cochrane Database Syst Rev; 2014 Jun; (6):CD009447. PubMed ID: 24966161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
